Pillar Biosciences oncoReveal™ CDx pan-cancer solid tumor IVD now FDA approved for general tumor profiling on the Illumina MiSeq™ Dx System

/PRNewswire/ -- Pillar Biosciences, Inc., the leader in Decision Medicine™, which develops and distributes next-generation sequencing (NGS) tests to localize...

Related Keywords

China ,Kevin Keegan ,Drug Administration ,Prnewswire Pillar Biosciences Inc ,Decision Medicine ,Premarket Approval ,Gang Song ,Executive Chairman ,Illumina Miseq ,Pillar Biosciences ,General Manager ,Pillar Biosciences Inc ,